Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 1/Phase 2"
topic_facet:"Lymphoma"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2FPhase+2%22&filter%5B%5D=topic_facet%3A%22Lymphoma%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2FPhase+2%22&filter%5B%5D=topic_facet%3A%22Lymphoma%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2FPhase+2%22&filter%5B%5D=topic_facet%3A%22Lymphoma%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
PubPharm (269)
1
Safety and Efficacy of Bendamustine, Gemcitabine, Rituximab, Nivolumab (BeGeRN) in Patients With r/r DLBCL : A Phase I/II Clinical Trial to Evaluate the Safety and Efficacy of Bendamustine, Gemcitabine, Rituximab, Nivolumab Combination (BeGeRN) in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
2
A Study of Atezolizumab in Combination With Either Obinutuzumab Plus Bendamustine or Obinutuzumab Plus (+) Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Participants With Follicular Lymphoma (FL) or Rituximab + CHOP in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) : A Phase IB/II Study Evaluating the Safety and Efficacy of Atezolizumab in Combination With Either Obinutuzumab Plus Bendamustine or Obinutuzumab Plus CHOP in Patients With Follicular Lymphoma or Rituximab Plus CHOP in Patients With Diffuse Large B-Cell Lymphoma
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
3
Azacytidine, Bendamustine, Piamprizumab in Refractory/Relapsed B-cell Non-Hodgkin's Lymphoma : An Open Label, Single Arm, Phase I/II in the Combination of Azacytidine, Bendamustine and Piamprizumab in Refractory/Relapsed B-cell Non-Hodgkin's
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
4
Outpatient Administration of R-DHAP in Relapsed/Refractory Non-Hodgkin Lymphoma : Safety and Efficacy of an Outpatient Schedule of Rituximab, Cytarabine, Carboplatin, and Dexamethasone in Relapsed/Refractory Non-Hodgkin Lymphoma. Phase I/II Trial.
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
5
Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma : Phase II Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma Patients
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
6
Pembrolizumab in Relapsed or Refractory Extranodal NK/T- Cell Lymphoma, Nasal Type and EBV-associated Diffuse Large B Cell Lymphomas : Phase I/II Study of Pembrolizumab in Patients With Relapsed or Refractory Extranodal NK/T- Cell Lymphoma (ENKTL), Nasal Type and EBV-associated Diffuse Large B Cell Lymphomas (EBV-DLBCL)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
7
An Open-label, Phase I/II Study of Manganese Plus Radiotherapy in Patients With Metastatic Solid Tumors or Lymphoma : A Phase I/II, Open-label Study to Evaluate the Abscopal Response and Safety of Manganese and Standard-of-care Radiotherapy/ SBRT in Subjects With Metastatic Solid Tumors or Lymphoma
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
8
Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma Patients : An Open-label, Multi-center, Single-arm Phase 1/2 Study to Assess Tolerability, Safety and Efficacy of CRC01 in Adult Patients With Relapsed or Refractory Large B-cell Lymphoma
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
9
A Phase I/II Study of Diffuse Large B-cell Lymphoma : A Phase I/II Study of Relapse/Refractory Diffuse Large B-cell Lymphoma
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
10
CD19-CAR_Lenti T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and DLBCL or PML : Phase I/II Study of Anti-CD19 Chimeric Antigen Receptor-Expressing T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia and Diffuse Large B Cell Lymphoma (DLBCL) or Primary Mediastinal B Cell Lymphoma (PML)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[27]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 1/Phase 2
Filter aufheben
Thema: Lymphoma
Medienart
269
Aufsätze
269
E-Artikel
269
E-Ressourcen
Zeitschriftentitel
269
ClinicalTrials.gov
Thema
269
610
Lymphoma
Phase: Phase 1/Phase 2
269
Study Type: Interventional
129
Recruitment Status: Completed
84
Lymphoma, Non-Hodgkin
70
Lymphoma, B-Cell
67
Leukemia
58
Lymphoma, Large B-Cell, Diffuse
42
Lymphoma, Mantle-Cell
41
Recruitment Status: Terminated
39
Leukemia, Lymphoid
37
Hodgkin Disease
37
Leukemia, Lymphocytic, Chronic, B-Cell
37
Recruitment Status: Unknown status
31
Lymphoma, T-Cell
31
Medical Condition: Lymphoma
31
Precursor Cell Lymphoblastic Leukemia-Lymphoma
28
Lymphoma, Follicular
28
Recruitment Status: Withdrawn
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
81
2020-
181
2010-2019
7
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
269
Englisch
Haven't found what you're looking for?
Wird geladen...